Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 4, 2016, Pages

  van Agteren, Joseph Em ^a   Hnin, Khin ^b   Carson, Kristin V ^c   Grosser, Dion ^a   Smith, Brian J ^c  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SEALANT;

AIRWAY BYPASS STENT; BRONCHOSCOPIC LUNG VOLUME REDUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; ENDOBRONCHIAL VALVE; HUMAN; INTERVENTION STUDY; INTRABRONCHIAL VALVE; LONG TERM CARE; LUNG RESECTION; NITINOL COIL; PRIORITY JOURNAL; REVIEW; STENT; SURGICAL EQUIPMENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VALVE;

EID: 84963772128     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD012158     Document Type: Review

References (83)

1. Bagdonas E, Raudoniute J, Bruzauskaite I, Aldonyte R. Novel aspects of pathogenesis and regeneration mechanisms in COPD. International Journal of Chronic Obstructive Pulmonary Disease 2015;10:995-1013. [DOI: 10.2147/COPD.S82518]
2. Biederer J, Beer M, Hirsch W, Wild J, Fabel M, Puderbach M, et al. MRI of the lung (2/3). Why ... when ... how?. Insights Imaging 2012;3(4):355-71. [DOI: 10.1007/s13244-011-0146-8]
3. Bourdin A, Burgel PR, Chanez P, Garcia G, Perez T, Roche N. Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities. European Respiratory Review 2009;18(114):198-212. [DOI: 10.1183/09059180.00005509]
4. Boutou AK, Zoumot Z, Nair A, Davey C, Hansell DM, Jamurtas A, et al. The impact of homogeneous versus heterogeneous emphysema on dynamic hyperinflation in patients with severe COPD assessed for lung volume reduction. Journal of Chronic Obstructive Pulmonary Disease 2015;0:1-8. [DOI: 10.3109/15412555.2015.1020149]
5. Campbell M, Grimshaw J, Steen N. Sample size calculations for cluster randomised trials. Journal of Health Services Research & Policy 2000;5(1):12-6.
6. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. European Respiratory Journal 2007;29(6):1224-38. [DOI: 10.1183/09031936.00109906]
7. Cetti EJ, Moore AJ, Geddes DM. Collateral ventilation. Thorax 2006;61(5):371-3. [DOI: 10.1136/thx.2006.060509]
8. Choong CK, Macklem PT, Pierce JA, Das N, Lutey BA, Martinez CO, et al. Airway bypass improves the mechanical properties of explanted emphysematous lungs. American Journal of Respiratory and Critical Care Medicine 2008;178(9):902-5. [DOI: 10.1164/rccm.200712-1832OC]
9. Cooper JD, Trulock EP, Triantafillou AN, Patterson GA, Pohl MS, Deloney RN, et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. Journal of Thoracic and Cardiovascular Surgery 1995;109(1):106-19.
10. Criner GJ, Sternberg AL. National Emphysema Treatment Trial: the major outcomes of lung volume reduction surgery in severe emphysema. Proceedings of the American Thoracic Society 2008;5(4):393-405. [DOI: 10.1513/pats.200801-013ET]
11. Criner GJ, Pinto-Plata V, Strange C, Dransfield M, Gotfried M, Leeds W, et al. Biologic lung volume reduction in advanced upper lobe emphysema: phase 2 results. American Journal of Respiratory and Critical Care Medicine 2009;179(9):791-8.
12. Criner GJ, Cordova F, Sternberg AL, Martinez FJ. The National Emphysema Treatment Trial (NETT) part II: lessons learned about lung volume reduction surgery. American Journal of Respiratory and Critical Care Medicine 2011;184(8):881-93.
13. Dal Negro R. Optimizing economic outcomes in the management of COPD. International Journal of Chronic Obstructive Pulmonary Disease 2008;3(1):1-10. [PUBMED: PMC2528207]
14. Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respiratory Research 2006;7(1):53. [DOI: 10.1186/1465-9921-7-53]
15. Eberhardt R, Gompelmann D, Herth FJF, Schuhmann M. Endoscopic bronchial valve treatment: patient selection and special considerations. International Journal of Chronic Obstructive Pulmonary Disease 2015;10:2147. [DOI: 10.2147/COPD.S63473]
16. Emery MJ, Eveland RL, Eveland K, Couetil LL, Hildebrandt J, Swenson ER. Lung volume reduction by bronchoscopic administration of steam. American Journal of Respiratory and Critical Care Medicine 2010;182(10):1282-91. [DOI: 10.1164/rccm.201001-0102OC]
17. Falkenstern-Ge RF, Ingerl H, Kohlhaeufl M. Treatment of severe advanced emphysema with volume reduction using lung sealant: a case report of 2 patients. Case Reports in Pulmonology 2013;20(1):58-62. [DOI: 10.1155/2013/361391]
18. Fann JI, Berry GJ, Burdon TA. Bronchoscopic approach to lung volume reduction using a valve device. Journal of Bronchology and Interventional Pulmonology 2003;10(4):253-9.
19. Ferguson GT. Why does the lung hyperinflate?. Proceedings of the American Thoracic Society 2006;3(2):176-9. [DOI: 10.1513/pats.200508-094DO]
20. Fessler HE, Permutt S. Lung volume reduction surgery and airflow limitation. American Journal of Respiratory and Critical Care Medicine 1998;157(3):715-22. [DOI: /10.1164/ajrccm.157.3.9608004]
21. Fessler HE, Scharf SM, Permutt S. Improvement in spirometry following lung volume reduction surgery: application of a physiologic model. American Journal of Respiratory and Critical Care Medicine 2002;165(1):34-40.
22. Fessler HE. Collateral ventilation, the bane of bronchoscopic volume reduction. American Journal of Respiratory and Critical Care Medicine 2005;171(5):423-4.
23. Fessler HE, Scharf SM, Ingenito EP, McKenna RJ Jr, Sharafkhaneh A. Physiologic basis for improved pulmonary function after lung volume reduction. Proceedings of the American Thoracic Society 2008;5(4):416-20. [DOI: 10.1513/pats.200708-117ET]
24. Galluccio G, Lucantoni G. Bronchoscopic lung volume reduction for pulmonary emphysema: preliminary experience with a new NOVATECH® endobronchial silicone one-way valve. Interactive CardioVascular and Thoracic Surgery 2010;11(2):213-5. [DOI: 10.1510/icvts.2010.236398]
25. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. http://www.goldcopd.org/ (accessed 2 February 2016).
26. GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 2 February 2016. Hamilton (ON): GRADE Working Group, McMaster University, 2014.
27. Herth FJF, Eberhard R, Gompelmann D, Slebos D-J, Ernst A. Bronchoscopic lung volume reduction with a dedicated coil: a clinical pilot study. Therapeutic Advances in Respiratory Disease 2010;4(4):225-31. [DOI: 10.1177/1753465810368553]
28. Herth FJF, Gompelmann D, Stanzel F, Bonnet R, Behr J, Schmidt B, et al. Treatment of advanced emphysema with emphysematous lung sealant (AeriSeal®). Interventional Pulmonology 2011;82(1):36-45. [DOI: 10.1159/000322649]
29. Herth FJF, Eberhardt R, Ingenito EP, Gompelmann D. Assessment of a novel lung sealant for performing endoscopic volume reduction therapy in patients with advanced emphysema. Expert Review of Medical Devices 2011;8(3):307-12. [DOI: 10.1586/erd.11.10]
30. Herth FJF, Ernst A, Baker KM, Egan JJ, Gotfried MH, Hopkins P, et al. Characterization of outcomes 1 year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema. International Journal of Chronic Obstructive Pulmonary Disease 2012;7:397-405. [DOI: 10.2147/COPD.S31082]
31. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
32. Higuchi T, Reed A, Oto T, Holsworth L, Ellis S, Bailey MJ, et al. Relation of interlobar collaterals to radiological heterogeneity in severe emphysema. Thorax 2006;61(5):409-13. [DOI: 10.1136/thx.2005.051219]
33. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. The Lancet 2004;364(9435):709-21.
34. Hopkinson NS, Toma TP, Hansell DM, Goldstraw P, Moxham J, Geddes DM, et al. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. American Journal of Respiratory and Critical Care Medicine 2005;171(5):453-60. [DOI: 10.1164/rccm.200407-961OC]
35. Hopkinson NS, Kemp SV, Toma TP, Hansell DM, Geddes DM, Shah PL, et al. Atelectasis and survival after bronchoscopic lung volume reduction for COPD. European Respiratory Journal 2011;37(6):1346-51. [DOI: 10.1183/09031936.00100110]
36. Ingenito EP, Reilly JJ, Mentzer SJ, Swanson SJ, Vin R, Keuhn H, et al. Bronchoscopic volume reduction: a safe and effective alternative to surgical therapy for emphysema. American Journal of Respiratory and Critical Care Medicine 2001;164(2):295-301.
37. Ingenito EP, Tsai LW, Majumdar A, Suki B. On the role of surface tension in the pathophysiology of emphysema. American Journal of Respiratory and Critical Care Medicine 2005;171(4):300-4. [DOI: 10.1164/rccm.200406-770PP]
38. Ingenito EP, Wood DE, Utz JP. Bronchoscopic lung volume reduction in severe emphysema. Proceedings of the American Thoracic Society 2008;5(4):454-60. [DOI: 10.1513/pats.200707-085ET]
39. Kim V, Rogers TJ, Criner GJ. New concepts in the pathobiology of chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 2008;5(4):478-85. [PUBMED: 18453359]
40. Kirkham PA, Barnes PJ. Oxidative stress in COPD. Chest 2013;144(1):266-73. [DOI: 10.1378/chest.12-2664]
41. Klooster K, ten Hacken NHT, Slebos D-J. The lung volume reduction coil for the treatment of emphysema: a new therapy in development. Expert Review of Medical Devices 2014;11(5):481-9. [DOI: 10.1586/17434440.2014.929490]
42. Klooster K, ten Hacken NHT, Franz I, Kerstjens HAM, van Rikxoort EM, Slebos D-J. Lung volume reduction coil treatment in chronic obstructive pulmonary disease patients with homogeneous emphysema: a prospective feasibility trial. Respiration 2014;88(2):116-25. [DOI: 10.1159/000362522]
43. Lausberg HF, Chino K, Patterson GA, Meyers BF, Toeniskoetter PD, Cooper JD. Bronchial fenestration improves expiratory flow in emphysematous human lungs. Annals of Thoracic Surgery 2003;75(2):393-8.
44. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 2013;380(9859):2095-128. [DOI: 10.1016/S0140-6736(12)61728-0]
45. Mair G, Miller JJ, McAllister D, Maclay J, Connell M, Murchison JT, et al. Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers. European Respiratory Journal 2009;33(3):536-42. [DOI: 10.1183/09031936.00111808]
46. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370(9589):765-73. [DOI: 10.1016/S0140-6736(07)61380-4]
47. Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 2007;4(7):502-6. [DOI: 10.1513/pats.200701-001FM]
48. Maxfield RA. New and emerging minimally invasive techniques for lung volume reduction. Chest 2004;125(2):777-83.
49. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2015, issue 2. [DOI: 10.1002/14651858.CD003793.pub3]
50. McNulty W, Jordan S, Hopkinson NS. Attitudes and access to lung volume reduction surgery for COPD: a survey by the British Thoracic Society. BMJ Open Respiratory Research 2014;1(1):e000023. [DOI: 10.1136/bmjresp-2014-000023]
51. Miller JD, Malthaner RA, Goldsmith CH, Goeree R, Higgins D, Cox PG, et al. A randomized clinical trial of lung volume reduction surgery versus best medical care for patients with advanced emphysema: a two-year study from Canada. Annals of Thoracic Surgery 2006;81(1):314-21. [PUBMED: 16368389]
52. Moher D, Liberati A, Tetzlaff J, Altman D. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine 2009;6(7):e1000097. [DOI: 10.1371/journal.pmed.1000097]
53. Mura M, Zompatori M, Mussoni A, Fasano L, Pacilli AM Grazia, Ferro O, et al. Bullous emphysema versus diffuse emphysema: a functional and radiologic comparison. Respiratory Medicine 2005;99(2):171-8. [DOI: 10.1016/j.rmed.2004.06.010]
54. The National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. https://www.nice.org.uk/guidance/cg101 (accessed 15 April 2016).
55. Papandrinopoulou D, Tzouda V, Tsoukalas G. Lung compliance and chronic obstructive pulmonary disease. Pulmonary Medicine 2012;2012:1-6. [DOI: 10.1155/2012/542769]
56. Perera PN, Armstrong EP, Sherrill DL, Skrepnek GH. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. Journal of Chronic Obstructive Pulmomary Disease 2012;9(2):131-41. [DOI: 10.3109/15412555.2011.650239]
57. Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI: 10.1002/14651858.CD005305.pub3]
58. Ramsey SD, Shroyer AL, Sullivan SD, Wood DE. Updated evaluation of the cost-effectiveness of lung volume reduction surgery. Chest 2007;131(3):823-32.
59. Refaely Y, Dransfield M, Kramer MR, Gotfried M, Leeds W, McLennan G, et al. Biologic lung volume reduction therapy for advanced homogeneous emphysema. European Respiratory Journal 2010;36(1):20-7. [DOI: 10.1183/09031936.00106009]
60. Rendina EA, De Giacomo T, Venuta F, Coloni GF, Meyers BF, Patterson GA, et al. Feasibility and safety of the airway bypass procedure for patients with emphysema. Journal of Thoracic and Cardiovacular Surgery 2003;125(6):1294-7.
61. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
62. Sharafkhaneh A, Hanania NA, Kim V. Pathogenesis of emphysema: from the bench to the bedside. Proceedings of the American Thoracic Society 2008;5(4):475-7. [DOI: 10.1513/pats.200708-126ET]
63. Snell GI, Holsworth L, Borrill ZL, Thomson KR, Kalff V, Smith JA, et al. The potential for bronchoscopic lung volume reduction using bronchial prostheses: a pilot study. Chest 2003;124(3):1073-80.
64. Snell GI, Hopkins P, Westall G, Holsworth L, Carle A, Williams TJ. A feasibility and safety study of bronchoscopic thermal vapor ablation: a novel emphysema therapy. The Annals of Thoracic Surgery 2009;88(6):1993-8. [DOI: 10.1016/j.athoracsur.2009.06.038]
65. Snell G, Herth FJF, Hopkins P, Baker KM, Witt C, Gotfried MH, et al. Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. European Respiratory Journal 2012;39(6):1326-33. [DOI: 10.1183/09031936.00092411]
66. Stockley RA, Mannino D, Barnes PJ. Burden and pathogenesis of chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 2009;6(6):524-6. [DOI: 10.1513/pats.200904-016DS]
67. Storbeck B, Schröder TH, Oldigs M, Rabe KF, Weber C. Emphysema: imaging for endoscopic lung volume reduction [Lungenemphysem: Bildgebung bei endoskopischerLungenvolumenreduktion]. Fortschritte auf dem Gebiet der Röntgenstrahlen und bildgebenden Verfahren 2015;187:543-54. [DOI: 10.1055/s-0034-1399424]
68. Suki B, Lutchen KR, Ingenito EP. On the progressive nature of emphysema: roles of proteases, inflammation, and mechanical forces. American Journal of Respiratory and Critical Care Medicine 2003;168(5):516-21. [DOI: 10.1164/rccm.200208-908PP]
69. Taraseviciene-Stewart L, Voelkel NF. Molecular pathogenesis of emphysema. Journal of Clinical Investigation 2008;118(2):394-402. [DOI: 10.1172/JCI31811]
70. Tiong LU, Gibson PG, Hensley MJ, Hepworth R, Lasserson TJ, Smith B, et al. Lung volume reduction surgery for diffuse emphysema. Cochrane Database of Systematic Reviews 2006, Issue 18. [DOI: 10.1002/14651858.CD001001.pub2]
71. Toma TP, Hopkinson NS, Hillier J, Hansell DM, Morgan C, Goldstraw PG, et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. The Lancet 2003;361(9361):931-3.
72. Tuder RM, McGrath S, Neptune E. The pathobiological mechanisms of emphysema models: what do they have in common?. Pulmonary Pharmacology and Therapeutics 2003;16(2):67-78.
73. Venuta F, de Giacomo T, Rendina EA, Ciccone AM, Diso D, Perrone A, et al. Bronchoscopic lung-volume reduction with one-way valves in patients with heterogenous emphysema. Annals of Thoracic Surgery 2005;79(2):411-6. [DOI: 10.1016/j.athoracsur.2004.07.048]
74. Venuta F, Rendina EA, De Giacomo T, Anile M, Diso D, Andreetti C, et al. Bronchoscopic procedures for emphysema treatment. European Journal of Cardio-thoracic Surgery 2006;29(3):281-7. [DOI: 10.1016/j.ejcts.2005.12.009]
75. Weder W, Thurnheer R, Stammberger U, Bürge M, Russi EW, Bloch KE. Radiologic emphysema morphology is associated with outcome after surgical lung volume reduction. Annals of Thoracic Surgery 1997;64(2):313-20.
76. Weder W, Tutic M, Bloch KE. Lung volume reduction surgery in nonheterogeneous emphysema. Thoracic Surgery Clinics 2009;19(2):193-9. [DOI: 10.1016/j.thorsurg.2009.03.002]
77. Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respiratory Care 2003;48(12):1204-15.
78. Wedzicha JA, Decramer M, Seemungal TAR. The role of bronchodilator treatment in the prevention of exacerbations of COPD. European Respiratory Journal 2012;40(6):1545-54. [DOI: 10.1183/09031936.00048912]
79. Welte T, Vogelmeier C, Papi A. COPD: early diagnosis and treatment to slow disease progression. International Journal of Clinical Practice 2015;69(3):336-49. [DOI: 10.1111/ijcp.12522]
80. Wood DE, McKenna RJ, Yusen RD, Sterman DH, Ost DE, Springmeyer SC, et al. A multicenter trial of an intrabronchial valve for treatment of severe emphysema. Journal of Thoracic and Cardiovascular Surgery 2007;133(1):65-73. [DOI: 10.1016/j.jtcvs.2006.06.051]
81. Yim APC, Hwong TMT, Lee TW, Li WWL, Lam S, Yeung TK, et al. Early results of endoscopic lung volume reduction for emphysema. Journal of Thoracic and Cardiovascular Surgery 2004;127(6):1564-73. [DOI: 10.1016/j.jtcvs.2003.10.005]
82. Zoumot Z, Jordan S, Hopkinson NS. Emphysema: time to say farewell to therapeutic nihilism. Thorax 2014;69(11):973-5. [DOI: 10.1136/thoraxjnl-2014-205667]
83. Zoumot Z, LoMauro A, Aliverti A, Nelson C, Ward S, Jordan S, et al. Lung volume reduction in emphysema improves chest wall asynchrony. Chest 2015;148(1):185-95. [DOI: 10.1378/chest.14-2380]